Bosman Wealth Management LLC Takes $1.70 Million Position in Oscar Health, Inc. $OSCR

Key Points

• Bosman Wealth Management LLC has acquired a new stake in Oscar Health, Inc., investing approximately $1.70 million for 79,382 shares, making it the firm's 26th largest holding.
• Insider Mario Schlosser sold 395,000 shares of Oscar Health for over $7.2 million, reducing his position by 44.08% and now holds shares valued at approximately $9.2 million.
• Several analysts have downgraded Oscar Health’s stock ratings, with the company currently holding a consensus rating of "Strong Sell" and a target price of $12.07.

Bosman Wealth Management LLC acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 79,382 shares of the company's stock, valued at approximately $1,702,000. Oscar Health accounts for about 1.5% of Bosman Wealth Management LLC's investment portfolio, making the stock its 26th biggest holding.

A number of other institutional investors have also recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its stake in Oscar Health by 23.8% in the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock worth $3,749,000 after acquiring an additional 54,938 shares during the period. Concurrent Investment Advisors LLC purchased a new stake in Oscar Health in the first quarter worth $677,000. Nuveen LLC bought a new position in Oscar Health in the first quarter worth $29,684,000. NewEdge Advisors LLC raised its holdings in Oscar Health by 89.7% in the first quarter. NewEdge Advisors LLC now owns 188,058 shares of the company's stock worth $2,465,000 after purchasing an additional 88,946 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. raised its holdings in Oscar Health by 19.0% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 501,972 shares of the company's stock worth $6,581,000 after purchasing an additional 79,979 shares in the last quarter. Hedge funds and other institutional investors own 75.70% of the company's stock.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the completion of the sale, the insider directly owned 501,148 shares in the company, valued at approximately $9,236,157.64. This trade represents a 44.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 25.11% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on OSCR shares. Piper Sandler decreased their price objective on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Raymond James Financial downgraded Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price objective (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Finally, UBS Group reiterated a "sell" rating and issued a $11.00 price objective (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Four analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $19.14 on Tuesday. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $22.78. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The business has a fifty day moving average price of $16.67 and a 200-day moving average price of $15.43. The company has a market capitalization of $4.95 billion, a PE ratio of -23.63 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same period last year, the company earned $0.20 EPS. Oscar Health's revenue for the quarter was up 29.0% on a year-over-year basis. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.